Drug Profile
Lamivudine/zidovudine/nevirapine - Aurobindo Pharma
Alternative Names: Lamivudine/nevirapine/zidovudine - Aurobindo Pharma; Nevirapine/lamivudine/zidovudine - Aurobindo Pharma; Nevirapine/zidovudine/lamivudine - Aurobindo Pharma; Zidovudine/lamivudine/nevirapine - Aurobindo Pharma; Zidovudine/nevirapine/lamivudine - Aurobindo PharmaLatest Information Update: 23 Nov 2018
Price :
$50
*
At a glance
- Originator Aurobindo Pharma
- Class 3-ring heterocyclic compounds; Antiretrovirals; Azepines; Azides; Cyclopropanes; Deoxyribonucleosides; Dideoxynucleosides; Nucleosides; Pyridines; Pyrimidine nucleosides; Small molecules
- Mechanism of Action Non-nucleoside reverse transcriptase inhibitors; Nucleoside reverse transcriptase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Registered HIV-1 infections
Most Recent Events
- 23 Nov 2018 Drug lamivudine/zidovudine/nevirapine is not yet available in USA for HIV-1 infections (Aurobindo Pharma website, November 2018)